Abstract
P-320 ARCADE (20090160): A randomized controlled trial of darbepoetin alpha in anemic patients with low or intermediate-1 risk myelodysplastic syndrome (MDS)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have